Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash from Operations (2016 - 2025)

Standard Biotools (LAB) has disclosed Cash from Operations for 16 consecutive years, with 1190000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 91.54% to 1190000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 74343000.0 through Dec 2025, up 48.18% year-over-year, with the annual reading at 74343000.0 for FY2025, 48.18% up from the prior year.
  • Cash from Operations for Q4 2025 was 1190000.0 at Standard Biotools, up from 22202000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 1190000.0 in Q4 2025, with the low at 62476000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 22525210.53, with a median of 20668000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations crashed 887.99% in 2021, then surged 91.54% in 2025.
  • Over 5 years, Cash from Operations stood at 37059000.0 in 2021, then skyrocketed by 48.24% to 19181000.0 in 2022, then increased by 26.69% to 14061000.0 in 2023, then increased by 0.01% to 14059000.0 in 2024, then soared by 91.54% to 1190000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1190000.0, 22202000.0, and 20668000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.